
Melissa Jean Perreira
Examiner (ID: 10386, Phone: (571)272-1354 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1065 |
| Issued Applications | 491 |
| Pending Applications | 87 |
| Abandoned Applications | 511 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16549722
[patent_doc_number] => 10882871
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => 18/19F-labelled compounds which target the prostate specific membrane antigen
[patent_app_type] => utility
[patent_app_number] => 16/068992
[patent_app_country] => US
[patent_app_date] => 2017-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14383
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16068992
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/068992 | 18/19F-labelled compounds which target the prostate specific membrane antigen | Jan 9, 2017 | Issued |
Array
(
[id] => 12466410
[patent_doc_number] => 09987378
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-05
[patent_title] => Prussian blue-inspired constructs for multimodal imaging and therapy
[patent_app_type] => utility
[patent_app_number] => 15/390106
[patent_app_country] => US
[patent_app_date] => 2016-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 59
[patent_no_of_words] => 10052
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15390106
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/390106 | Prussian blue-inspired constructs for multimodal imaging and therapy | Dec 22, 2016 | Issued |
Array
(
[id] => 14820841
[patent_doc_number] => 10407412
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-10
[patent_title] => Dimeric contrast agents
[patent_app_type] => utility
[patent_app_number] => 16/060754
[patent_app_country] => US
[patent_app_date] => 2016-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9954
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060754
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/060754 | Dimeric contrast agents | Dec 11, 2016 | Issued |
Array
(
[id] => 11962175
[patent_doc_number] => 20170266326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 15/364678
[patent_app_country] => US
[patent_app_date] => 2016-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 91431
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15364678
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/364678 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS | Nov 29, 2016 | Abandoned |
Array
(
[id] => 16743250
[patent_doc_number] => 10968224
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => 2,11-diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of essential metal ion based MRI contrast agents and 52MN based PET contrast agents
[patent_app_type] => utility
[patent_app_number] => 15/778489
[patent_app_country] => US
[patent_app_date] => 2016-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6233
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778489
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/778489 | 2,11-diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of essential metal ion based MRI contrast agents and 52MN based PET contrast agents | Nov 24, 2016 | Issued |
Array
(
[id] => 12750931
[patent_doc_number] => 20180142144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => LUMINOGENIC TRANSITION METAL-BASED PYRIDYL COMPLEX AND ITS USE
[patent_app_type] => utility
[patent_app_number] => 15/359736
[patent_app_country] => US
[patent_app_date] => 2016-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15359736
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/359736 | Luminogenic transition metal-based pyridyl complex and its use | Nov 22, 2016 | Issued |
Array
(
[id] => 11627727
[patent_doc_number] => 20170137916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'METHOD FOR PURIFICATION OF 225AC FROM IRRADIATED 226RA-TARGETS'
[patent_app_type] => utility
[patent_app_number] => 15/359053
[patent_app_country] => US
[patent_app_date] => 2016-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9366
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15359053
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/359053 | Method for purification of 225AC from irradiated 226RA-targets | Nov 21, 2016 | Issued |
Array
(
[id] => 12151503
[patent_doc_number] => 20180022768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'RADIOACTIVE PHOSPHOLIPID METAL CHELATES FOR CANCER IMAGING AND THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/343604
[patent_app_country] => US
[patent_app_date] => 2016-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 9107
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15343604
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/343604 | RADIOACTIVE PHOSPHOLIPID METAL CHELATES FOR CANCER IMAGING AND THERAPY | Nov 3, 2016 | Abandoned |
Array
(
[id] => 14182911
[patent_doc_number] => 20190111160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => MANGANESE COMPLEXES WITH SUBSTITUTED BISPHOSPHONATES USEFUL AS IMAGING AND THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/095076
[patent_app_country] => US
[patent_app_date] => 2016-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095076
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095076 | Manganese complexes with substituted bisphosphonates useful as imaging and therapeutic agents | Oct 25, 2016 | Issued |
Array
(
[id] => 13458017
[patent_doc_number] => 20180280551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => LABELING OF ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 15/764087
[patent_app_country] => US
[patent_app_date] => 2016-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -127
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15764087
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/764087 | Labeling of antibodies | Sep 30, 2016 | Issued |
Array
(
[id] => 13410437
[patent_doc_number] => 20180256761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => MIBG ANALOGS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/762406
[patent_app_country] => US
[patent_app_date] => 2016-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15762406
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/762406 | MIBG analogs and uses thereof | Sep 22, 2016 | Issued |
Array
(
[id] => 11362758
[patent_doc_number] => 20170000739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'ABUSE-PROOFED DOSAGE FORM'
[patent_app_type] => utility
[patent_app_number] => 15/265263
[patent_app_country] => US
[patent_app_date] => 2016-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10951
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15265263
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/265263 | Abuse-proofed dosage form | Sep 13, 2016 | Issued |
Array
(
[id] => 13430947
[patent_doc_number] => 20180267016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => PURE NON-INVASIVE METHOD FOR IDENTIFICATION OF ORGAN DISEASES OR IMPAIRED ORGAN FUNCTION BY INVESTIGATION OF MARKER SUBSTANCES IN EXHALED AIR STIMULATED BY INHALED MARKER SUBSTANCES
[patent_app_type] => utility
[patent_app_number] => 15/760211
[patent_app_country] => US
[patent_app_date] => 2016-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760211
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/760211 | Pure non-invasive method for identification of organ diseases or impaired organ function by investigation of marker substances in exhaled air stimulated by inhaled marker substances | Sep 13, 2016 | Issued |
Array
(
[id] => 11992523
[patent_doc_number] => 20170296679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'Compositions of Near IR Closed Chain, Sulfo-Cyanine Dyes and Prostate Specific Membrane Antigen Ligands'
[patent_app_type] => utility
[patent_app_number] => 15/261357
[patent_app_country] => US
[patent_app_date] => 2016-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10674
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15261357
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/261357 | Compositions of Near IR Closed Chain, Sulfo-Cyanine Dyes and Prostate Specific Membrane Antigen Ligands | Sep 8, 2016 | Abandoned |
Array
(
[id] => 11921647
[patent_doc_number] => 09789208
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-17
[patent_title] => 'Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors'
[patent_app_type] => utility
[patent_app_number] => 15/259719
[patent_app_country] => US
[patent_app_date] => 2016-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 58
[patent_no_of_words] => 15484
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15259719
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/259719 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | Sep 7, 2016 | Issued |
Array
(
[id] => 11348969
[patent_doc_number] => 20160367709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'DEVICES AND METHODS FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/255220
[patent_app_country] => US
[patent_app_date] => 2016-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8223
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15255220
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/255220 | DEVICES AND METHODS FOR THE TREATMENT OF CANCER | Sep 1, 2016 | Abandoned |
Array
(
[id] => 13397721
[patent_doc_number] => 20180250403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 15/754573
[patent_app_country] => US
[patent_app_date] => 2016-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15754573
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/754573 | CONJUGATES | Aug 23, 2016 | Abandoned |
Array
(
[id] => 13397725
[patent_doc_number] => 20180250405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => COMPOSITIONS, COMBINATIONS AND RELATED METHODS FOR PHOTOIMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 15/753153
[patent_app_country] => US
[patent_app_date] => 2016-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 91252
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -196
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15753153
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/753153 | Compositions, combinations and related methods for photoimmunotherapy | Aug 17, 2016 | Issued |
Array
(
[id] => 17059019
[patent_doc_number] => 11103601
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-31
[patent_title] => Lymph targeting nuclear magnetic contrast agent using brown algae polysaccharide as carrier and preparation method and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/760650
[patent_app_country] => US
[patent_app_date] => 2016-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 10087
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760650
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/760650 | Lymph targeting nuclear magnetic contrast agent using brown algae polysaccharide as carrier and preparation method and use thereof | Aug 17, 2016 | Issued |
Array
(
[id] => 16443719
[patent_doc_number] => 10835623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => Manganese-based chelate conjugates for molecular MR imaging
[patent_app_type] => utility
[patent_app_number] => 15/751617
[patent_app_country] => US
[patent_app_date] => 2016-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 8
[patent_no_of_words] => 22179
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 296
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15751617
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/751617 | Manganese-based chelate conjugates for molecular MR imaging | Aug 11, 2016 | Issued |